These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31898424)

  • 1. Characteristics of Faecal Microbiota in Korean Patients with
    Jeon YD; Ann HW; Lee WJ; Kim JH; Seong H; Kim JH; Ahn JY; Jeong SJ; Ku NS; Yeom JS; Yong D; Lee K; Choi JY
    Infect Chemother; 2019 Dec; 51(4):365-375. PubMed ID: 31898424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China.
    Dong D; Ni Q; Wang C; Zhang L; Li Z; Jiang C; EnqiangMao ; Peng Y
    BMC Infect Dis; 2018 May; 18(1):207. PubMed ID: 29724187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic
    Han SH; Yi J; Kim JH; Moon AH
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32545219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention.
    Halpin AL; de Man TJ; Kraft CS; Perry KA; Chan AW; Lieu S; Mikell J; Limbago BM; McDonald LC
    Am J Infect Control; 2016 Jul; 44(7):830-6. PubMed ID: 26905790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Composition Associated with
    Martinez E; Taminiau B; Rodriguez C; Daube G
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890026
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interactions between intestinal microbiota and Clostridioides difficile].
    Barbut F; Couturier J
    Rev Prat; 2019 Sep; 69(7):784-791. PubMed ID: 32233325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by
    Crobach MJT; Ducarmon QR; Terveer EM; Harmanus C; Sanders IMJG; Verduin KM; Kuijper EJ; Zwittink RD
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32384826
    [No Abstract]   [Full Text] [Related]  

  • 8. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load.
    Han SH; Yi J; Kim JH; Lee S; Moon HW
    PLoS One; 2019; 14(2):e0212626. PubMed ID: 30785932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent
    Santiago M; Eysenbach L; Allegretti J; Aroniadis O; Brandt LJ; Fischer M; Grinspan A; Kelly C; Morrow C; Rodriguez M; Osman M; Kassam Z; Smith MB; Timberlake S
    AIMS Microbiol; 2019; 5(1):1-18. PubMed ID: 31384699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
    Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
    Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
    Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal microbiota characterisation of horses using 16 rdna barcoded pyrosequencing, and carriage rate of clostridium difficile at hospital admission.
    Rodriguez C; Taminiau B; Brévers B; Avesani V; Van Broeck J; Leroux A; Gallot M; Bruwier A; Amory H; Delmée M; Daube G
    BMC Microbiol; 2015 Sep; 15():181. PubMed ID: 26377067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk.
    Davis MY; Zhang H; Brannan LE; Carman RJ; Boone JH
    Microbiome; 2016 Oct; 4(1):53. PubMed ID: 27717398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
    Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Tomas ME; Mana TSC; Wilson BM; Nerandzic MM; Joussef-Piña S; Quiñones-Mateu ME; Donskey CJ
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530853
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Fehlbaum S; Chassard C; Schwab C; Voolaid M; Fourmestraux C; Derrien M; Lacroix C
    Front Nutr; 2019; 6():184. PubMed ID: 31921877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.